For in vitro diagnostic use. Others Elecsys HIV Duo IVD Elecsys® HIV Duo CPS_000848 08836973160 HIV duo Elecsys E2G 300 V2 Elecsys HIV Duo 07613336215845 Reagents, kits 300 tests cobas e 402/801 true 07229542190 HIV duo Elecsys E2G 300 Elecsys HIV Duo 07613336119297 Reagents, kits 300 tests cobas e 402/801 true 08836973190 HIV duo Elecsys E2G 300 V2 Elecsys HIV Duo 07613336166949 Reagents, kits 300 tests cobas e 402/801 true 08836973192 HIV Duo Elecsys E2G 10x300 Elecsys HIV Duo 07613336224175 Reagents, kits 10 x 300 tests cobas e 402/801 true 08836973503 Elecsys HIV Duo en 3 FF0000000610EE0E FF00000005A58F0E 08836973160 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useElecsys HIV Duo is an immunoassay intended for the in vitro simultaneous qualitative detection and differentiation of HIV‑1 p24 antigen and antibodies to HIV, HIV‑1 (groups M and O) and HIV‑2 in human serum and plasma. Elecsys HIV Duo assay is intended to be used as an aid in the diagnosis of HIV‑1 and/or HIV‑2 infection, including acute or primary HIV‑1 infection. The assay may also be used as an aid in the diagnosis of HIV‑1/HIV‑2 infection in subjects greater than 2 years of age and in pregnant women. Elecsys HIV Duo is not intended for the screening of donors of blood and blood products or human cells, tissues, and cellular and tissue‑based products (HCT/Ps).Elecsys HIV Duo is an electrochemiluminescence immunoassay “ECLIA” intended for use on the cobas e 402 and cobas e 801 immunoassay analyzers. en 07229542500 Elecsys HIV Duo en 4 FF000000046CB60E FF00000001C3820E 07229542190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of HIV‑1 p24 antigen and antibodies to HIV‑1, including group O, and HIV‑2 in human serum and plasma. The subresults (HIV Ag and anti‑HIV) are intended as an aid in the selection of the confirmation algorithm for reactive samples.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 801 immunoassay analyzer. en 08836973500 Elecsys HIV Duo en 3 FF0000000526F00E FF00000003F94B0E 08836973190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of HIV‑1 p24 antigen and antibodies to HIV‑1, including group O, and HIV‑2 in human serum and plasma. The subresults (HIV Ag and anti‑HIV) are intended as an aid in the selection of the confirmation algorithm for reactive samples.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08836973500 Elecsys HIV Duo en 2 FF0000000446970E FF0000000446970E 08836973190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of HIV‑1 p24 antigen and antibodies to HIV‑1, including group O, and HIV‑2 in human serum and plasma. The subresults (HIV Ag and anti‑HIV) are intended as an aid in the selection of the confirmation algorithm for reactive samples.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08836973501 Elecsys HIV Duo en 1 FF0000000416C30E FF0000000416C30E 08836973190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useElecsys HIV Duo is an immunoassay intended for the in vitro simultaneous qualitative detection and differentiation of HIV‑1 p24 antigen and antibodies to HIV, HIV‑1 (groups M and O) and HIV‑2 in human serum and plasma. Elecsys HIV Duo assay is intended to be used as an aid in the diagnosis of HIV‑1 and/or HIV‑2 infection, including acute or primary HIV‑1 infection. The assay may also be used as an aid in the diagnosis of HIV‑1/HIV‑2 infection in subjects greater than 2 years of age and in pregnant women. Elecsys HIV duo is not intended for the screening of blood and plasma donors.Elecsys HIV Duo is an electrochemiluminescence immunoassay “ECLIA” intended for use on the cobas e 801 immunoassay analyzer. en 08836973500 Elecsys HIV Duo en 1 FF00000003F94B0E FF00000003F94A0E 08836973190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of HIV‑1 p24 antigen and antibodies to HIV‑1, including group O, and HIV‑2 in human serum and plasma. The subresults (HIV Ag and anti‑HIV) are intended as an aid in the selection of the confirmation algorithm for reactive samples.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 801 immunoassay analyzer. en 08836973503 Elecsys HIV Duo en 1 FF000000061DFF0E FF000000061DFF0E 08836973192 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of HIV‑1 p24 antigen and antibodies to HIV‑1, including group O, and HIV‑2 in human serum and plasma. The subresults (HIV Ag and anti‑HIV) are intended as an aid in the selection of the confirmation algorithm for reactive samples.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en